Drug Discovery News
-
Takeda gets NDA approval for VAXEM Hib vaccine in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2016
Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approve...Read more
-
Aspirin use increases risk of age-related eye disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...Read more
-
Systems Toxicology Computational Challenge explores toxicant prediction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2016
Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiativ...Read more
-
University of Dundee, Ono Pharma to collaborate on drug research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2016
A Japanese delegation will initiate a partnership with University of Dundee seeking to develop new treatments for inflam...Read more
-
FDA approves Eli Lilly's combination drug for metastatic colorectal cancer
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2015
Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Fo...Read more
-
Scientists use tiniest human protein to heal heart
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013
Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IM...Read more
-
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2016
Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to...Read more
-
BMS uses Santaris platform for drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Apr, 2013
Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disea...Read more
-
Mitsubishi Tanabe to manufacture diabetes drug Tenelia
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...Read more
-
Wockhardt increases investment in R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2015
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...Read more
-
Sosei' subsidiary Heptares records positive outcome of Schizophrenia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2016
Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corp...Read more
-
FDA warns against Mitshubi Tanabe's type 2 diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015
Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, I...Read more
-
Aussie anesthetic firm gets patent from 7 nations
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...Read more
-
Australia's TransBio, DendroCyte to develop antibody for transplant rejection
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2015
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...Read more
-
Daiichi Sankyo files NDA for Prasugrel in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...Read more
-
Orient launches prostate cancer drug in SE Asia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2014
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...Read more
-
Innate Immunotherapeutics completes $9mn IPO
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...Read more
-
Cadila Healthcare eyeing US, Europe markets
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...Read more
